1Coenye T, Vancanneyt M, Cnockaert M, et al. Kerstersia gyiorum gen. nov. , sp. nov. , a novel Alcaligenes faecalis-like organism isolated from human clinical samples, and reclassification of Alcaligenes denitrificans Ruger and Tan 1983 as Achromobacter denitrificans comb. nov [ J ]. Int J Syst Evol Microbiol, 2003,53 ( 6 ) : 1825-1831.
2Coenye T, Vancanneyt M, Falsen E, et al. Achromobacter insolitus sp. nov. and Achromobacter spanius sp. nov. , from human clinical sampies[J]. Int J Syst Evol Microbiol,2003,53 (6) :1819-1824.
3Kay S E, Clark R A, White K L, et al. Recurrent Achromobacter piechaudii bacteremia in a patient with hematological malignancy [ J ]. J Clin Microbiol,2001,39(2) :808-810.
4Sader H S ,Jones R N. Antimicrobial susceptibility of uncommonly iso-lated non-enteric Gram-negative bacilli[ J]. Int J Antimicrob Agents, 2005,25 (2) :95-109.
5Saiman L, Chen Y, Tabibi S, et al. Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis [ J ]. J Clin Microbiol,2001,39 ( 11 ) : 3942-3945.
6Shie S S, Huang C T, Leu H S. Characteristics of Achromobacter xylosoxidans bacteremia in northern Taiwan [ J ]. J Microbiol Immunol Infect, 2005,38 (4) : 277-282.
7Shin K S, Han K, Lee J, et al. Imipenem-resistant Achromobacter xylosoxidans carrying blaVIM-2-containing class 1 integron [ J ]. Diagn Microbiol Infect Dis ,2005,53 ( 3 ) :215-220.
8Neuwirth C, Freby C, Ogier-Desserrey A, et al. VEB-1 in Achromobacter xylosoxidans from cystic fibrosis patient, France [ J ]. Emerging Infectious Diseases ,2006,12 ( 11 ) : 1737-1739.
10Sofianou D, Markogiannakis A, Metzidie E, et al. VIM-2 metallo-beta-lactamase in Achromobacter xylosoxidans in Europe [ J ]. Eur J Clin Microbiol Infect Dis,2005,24 (12) :854-855.
